Karolina J. Janczura
Regenxbio (United States)(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Neuroscience and Neuropharmacology Research, Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Epigenetics and DNA Methylation
Most-Cited Works
- → RETRACTED: Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model(2018)188 cited
- → Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family(2011)95 cited
- → miR‐184 regulates ezrin, LAMP‐1 expression, affects phagocytosis in human retinal pigment epithelium and is downregulated in age‐related macular degeneration(2014)74 cited
- → Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins(2018)73 cited
- → M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory(2017)68 cited
- → NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia(2012)53 cited
- → Longevity‐related molecular pathways are subject to midlife “switch” in humans(2019)41 cited
- → NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer’s, and Ethanol Intoxication(2017)34 cited
- → The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB(2013)30 cited
- → NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test(2012)27 cited